Observer variability in histopathological reporting of non-small cell lung carcinoma on bronchial biopsy specimens.

Authors:
  • SHS R Howatson
    S R Howatson
  • SLS Lang
    S Lang
  • FLF D Lee
    F D Lee
  • ALA M Lessells
    A M Lessells
  • KMK M McLaren
    K M McLaren
  • ENE R Nairn
    E R Nairn
  • SOS Ogston
    S Ogston
  • ARA J Robertson
    A J Robertson
  • JSJ G Simpson
    J G Simpson
  • GSG D Smith
    G D Smith
  • HTH B Tavadia
    H B Tavadia

Abstract
AIMS: To evaluate the ability of histopathologists to sub-classify non-small cell lung carcinomas on bronchial biopsy material using the current World Health Organisation (WHO) classification. METHODS: Twelve histopathologists each reviewed 100 randomly selected bronchial biopsy specimens which had originally been reported as showing non-small cell lung carcinoma. For each case, two sections were circulated, one stained by haematoxylin and eosin and the other by a standard method for mucin (alcian blue/periodic acid Schiff). The participants were allowed to indicate their degree of confidence in their classification of each case. A standard proforma was completed and the results were analysed using kappa statistics. RESULTS: Where the participants were confident in their classification, they were actually quite good at sub-classifying the non-small cell carcinoma sections (kappa = 0.71, standard error = 0.058). Overall, however, the results were only fair (kappa = 0.39, standard error = 0.034). CONCLUSIONS: The majority of non-small cell lung carcinomas can be correctly categorised on adequate bronchial biopsy material. Where a confident diagnosis was made, both squamous carcinoma (kappa = 0.73) and adenocarcinoma (kappa = 0.83) were well recognised.